new/era/mabs GmbH

new/era/mabs is offering new and innovative technologies for the generation of monoclonal and recombinant antibodies. Our selection technology is patented and allows an easy and efficient screening and sorting of desired antibody producing cells in a very short time frame. Together with our immunisation strategy of chimeric viral particles we are able to serve you with your specific antibody in a very fast manner. Our portfolio includes the generation of murine, camelid and human antibodies and different recombinant formats. We love to support you with the development of a binder that fits your needs! Just contact us - we are happy to talk to you! The new/era/mabs team